相关实验视频
Updated: Feb 26, 2026

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
20.1K
快速:整合生化,计算和临床试验,以评估草药配方对SARS-CoV-2的疗效
Sudhir Dadram Patsute1, Suchitra Ganeshacharya1, Sarita Singh2
1Naidu Hospital, Infectious Diseases Centre, Pune, MH, India.
概括
这项研究表明,一种新的草药配方在体外和体内有效抑制了SARS-CoV-2. 临床试验证实了其作为补充COVID-19疗法的潜力,加速恢复并促进免疫反应.
科学领域:
- 综合医学是一个整体的医学.
- 病毒学 病毒学
- 计算生物学 计算生物学
背景情况:
- 由于COVID-19的流行,需要新的治疗策略.
- 阿育吠陀医学提供了潜在的补充治疗方法.
- 调查SARS-CoV-2管理的草药配方至关重要.
研究的目的:
- 评估针对COVID-19的特定草药配方的安全性和有效性.
- 通过体外,体内和临床方法评估抗病毒活性.
- 探索该配方作为COVID-19的辅助疗法的潜力.
主要方法:
- 在体外抗病毒测定 (斑块测定) 病毒抑制.
- 在基分子对接 (AutoDock4.2.6) 针对SARS-CoV-2的目标.
- 与COVID-19患者进行的开放标签和双盲临床试验.
主要成果:
- 草药配方在体外实现了94.51%的病毒载量减少.
- 在分析中,确定了20种具有有利结合亲和力的植物化合物.
- 临床试验表明,高恢复率 (93.3-96.7%在7天内) 和减少疾病进展.
结论:
- 这种草药配方表现出强大的抗病毒活性和对SARS-CoV-2的分子结合.
- 临床证据支持COVID-19患者的加速恢复和免疫调节.
- 该配方显示出作为有效的补充疗法对COVID-19管理的承诺.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.4K
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
1.6K
相关概念视频
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K